Target
Adenosine receptor A3
Ligand
BDBM204881
Substrate
n/a
Meas. Tech.
Radioligand Binding Assays
Ki
12.8±0 nM
Citation
 Jacobson, KAThatikonda, SKKozma, EESpalluto, GMoro, SFederico, S Fluorescent antagonists of the A3 adenosine receptor US Patent  US9227979 Publication Date 1/5/2016 
Target
Name:
Adenosine receptor A3
Synonyms:
A3 adenosine receptor (hA3) | AA3R_HUMAN | ADORA3 | Adenosine A3 receptor (A3AR)
Type:
G Protein-Coupled Receptor (GPCR)
Mol. Mass.:
36197.32
Organism:
Homo sapiens (Human)
Description:
P0DMS8
Residue:
318
Sequence:
MPNNSTALSLANVTYITMEIFIGLCAIVGNVLVICVVKLNPSLQTTTFYFIVSLALADIAVGVLVMPLAIVVSLGITIHFYSCLFMTCLLLIFTHASIMSLLAIAVDRYLRVKLTVRYKRVTTHRRIWLALGLCWLVSFLVGLTPMFGWNMKLTSEYHRNVTFLSCQFVSVMRMDYMVYFSFLTWIFIPLVVMCAIYLDIFYIIRNKLSLNLSNSKETGAFYGREFKTAKSLFLVLFLFALSWLPLSIINCIIYFNGEVPQLVLYMGILLSHANSMMNPIVYAYKIKKFKETYLLILKACVVCHPSDSLDTSIEKNSE
  
Inhibitor
Name:
BDBM204881
Synonyms:
EA20(5-oct-7-ynamide)/MRS5840 | US9227979, 39
Type:
Small organic molecule
Emp. Form.:
C19H19N7O2
Mol. Mass.:
377.3999
SMILES:
Cn1cc2c(n1)nc(NC(=O)CCCCCC#C)n1nc(nc21)-c1ccco1
Structure:
Search PDB for entries with ligand similarity: